Composition for enhancing the efficacy of antibody drugs – Japan Patent No. 7088502

Country of RegistrationJapan
Patent No.No. 7088502
Registration DateJune 13, 2022
This patent is for the combination of “antibody drugs” such as immune checkpoint inhibitors and β-glucan to enhance their effects.